NEWRON PHARMACEUT. EO-20 (NP5) — Defensive Interval Ratio
NEWRON PHARMACEUT. EO-20 (NP5) has a Defensive Interval Ratio of 140 days as of December 2025. Defensive assets of €19.23 Million (cash €-, short-term investments €16.69 Million, receivables €2.54 Million) cover 140 days of daily cash needs of €137.35K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
NEWRON PHARMACEUT. EO-20 Defensive Interval Ratio (2021–2025)
This chart shows how NEWRON PHARMACEUT. EO-20's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 140 days, meaning defensive assets of €19.23 Million can fund 140 days of operations without new revenue. For the complete balance sheet picture, see NEWRON PHARMACEUT. EO-20 asset portfolio.
Annual Defensive Interval Ratio for NEWRON PHARMACEUT. EO-20 (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for NEWRON PHARMACEUT. EO-20 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See NP5 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 140 days | €19.23 Million | €137.35K/day | €- | €16.69 Million | ▼ -559 days |
| 2024 | 699 days | €45.01 Million | €64.40K/day | €- | €2.89 Million | ▲ +594 days |
| 2023 | 105 days | €8.28 Million | €79.25K/day | €- | €6.26 Million | ▼ -713 days |
| 2022 | 818 days | €11.29 Million | €13.81K/day | €- | €9.35 Million | ▼ -269 days |
| 2021 | 1087 days | €10.88 Million | €10.01K/day | €- | €9.57 Million | — |